Sign in
Not yet taking people in United StatesNo phase

Testing an AI care companion tool for adults with diabetes or high blood pressure

Tests an AI care companion tool in adults with diabetes or hypertension.

Key facts

Who runs it
Fitbit LLC
Where
Portland, United StatesSee the site
Trial code
Registry title
Care COMPASS Study
Status
Not yet recruiting
People taking part
200 people, planned
Started
22 Oct 2026
Expected to end
30 Jul 2027
Type of study
Interventional
Treatments tested
  • Guide My Care Tool
Record updated
29 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with type 1 or type 2 diabetes and/or high blood pressure who go to outpatient clinic visits. It tests an AI Care Companion tool.

Age
18 years or older
Sex
All sexes can join.
Disease stage
Existing diagnosis of type 1 or type 2 diabetes and/or hypertension, with at least two outpatient visits in the past 12 months.
Earlier treatment
Must not have joined a health coaching trial now or in the last 6 months.

Main reasons for not taking part

  • Emergency or acute medical problem at the scheduled appointment
  • Pregnancy (self-reported or from medical records)
  • Already took part in this study
  • In a health coaching trial now or in the last 6 months
  • Any other condition or reason that the study doctor decides may affect taking part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Age: Legal adult (18+)
  • Existing diagnosis of Diabetes Mellitus Type 1 / 2 and/or hypertension who have had at least two outpatient visits in the prior 12 months
  • Scheduled in-person clinician appointment for follow up of Diabetes Mellitus -----Type 1 / 2 and/or hypertension within the next 4 months
  • Anticipate ongoing care with their current clinic for at least one month following their clinic visit for this research study
  • Able to contact their health care team as needed (by telephone, messaging or other) in the 2 weeks following their clinic visit
  • Able to read and write in English
  • Has an active patient portal account
  • Current user of smart phones
  • Access to wifi or internet

Who cannot take part

  • Any other medical condition or other reason- as determined by the principal investigator or designee - that may affect participant involvement, study procedures or data collection
  • Patients with emergency or acute medical issues arising at their scheduled appointment
  • Pregnancy (based on self-report or medical records),
  • Participants who have already participated in this study
  • Participating currently (or in the last 6 months) with a clinical trial of a health coaching intervention

Where in United States

  • Oregon Health Sciences UniversityPortland, United StatesContact: Jeffrey Gold, MDNot yet recruiting

About the trial

What the trial wants to find out

This is a prospective, single-arm, mixed-methods pilot study at a single academic medical center to observe the impact, feasibility and acceptability of an AI Care Companion tool on activation and confidence among patients with chronic disease attending outpatient care.

The group in the trial

  • Guide My Care ToolTreatment being tested

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Care COMPASS Study: (Care Companion for Patient Activation and Self-Support)
Plain-language title
Testing an AI care companion tool for adults with diabetes or high blood pressureGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 13 November 2026.
Record updated
29 October 2026